Ansa Biotechnologies, Inc., announced that it has synthesized and delivered complex clonal DNA sequences to multiple customers participating in its Early Access Program. Additionally, Ansa’s first ...
Interested in writing for CW? Compliance Week accepts outside contributions from corporate chief compliance officers and other senior-level GRC practitioners. To learn more, contact the CW Editor.
Ansa successfully synthesized and delivered challenging promoter sequences with high GC and AT content to its first Early Access customer, Enoda, which were used to engineer gene expression. Ansa’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results